Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-30

FDA Approved: DESVENLAFAXINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for desvenlafaxine (generic) sponsored by Hikma Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desvenlafaxine (Desvenlafaxine)

Snippet

SUPPL AP for DESVENLAFAXINE (DESVENLAFAXINE)